Qiagen N.V. at its AGM appointed Dr. Eva Pisa as new Supervisory Board member. Dr. Pisa, brings proven leadership insights and extensive industry experience to QIAGEN that will deeply enrich the capabilities in board in terms of science and business acumen. She most recently served at Roche Diagnostics International from 2007 to 2020, where she held various leadership positions of increasing responsibility.

During her tenure, the cobas 6,800 and 8,800 systems were developed and launched. Dr. Pisa, was also responsible for clinical chemistry, endocrinology and the custom biotech business at Roche as well. Before joining Roche, Dr. Pisa, was the CEO of Sangtec Molecular Diagnostics AB, a Swedish molecular diagnostic start-up.

Dr. Pisa, holds a PhD from the Karolinska Institute in Sweden and an MBA from Heriot-Watt University in Scotland.